VF
ADMA icon

Virtu Financial’s ADMA Biologics ADMA Stock Holding History

Virtu Financial’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,200
Closed -$281K – 1592
2025
Q3 		$281K Buy
19,200
+1,990
+12% +$34.1K 0.02% 766
2025
Q2 		$313K Buy
+17,210
New +$351K 0.02% 736
2025
Q1 		– Sell
-18,992
Closed -$326K – 1289
2024
Q4 		$326K Buy
+18,992
New +$357K 0.02% 663
2023
Q3 		– Sell
-24,684
Closed -$91K – 1225
2023
Q2 		$91K Buy
+24,684
New +$91.5K 0.01% 1058
2022
Q4 		– Sell
-36,123
Closed -$88K – 1528
2022
Q3 		$88K Buy
36,123
+18,935
+110% +$45.4K 0.01% 1111
2022
Q2 		$34K Buy
+17,188
New +$33.8K ﹤0.01% 1221
2022
Q1 		– Sell
-88,315
Closed -$125K – 1445
2021
Q4 		$125K Buy
+88,315
New +$116K 0.01% 1030
2020
Q4 		– Sell
-93,705
Closed -$224K – 1399
2020
Q3 		$224K Buy
+93,705
New +$257K 0.04% 556
2018
Q1 		– Sell
-23,188
Closed -$74K – 1891
2017
Q4 		$74K Buy
+23,188
New +$64.9K ﹤0.01% 1992

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Virtu Financial's ADMA Position: Q4 2025 in Review

Virtu Financial sold out of ADMA Biologics (ADMA) in Q4 2025, closing a stake of 19,200 shares — an estimated $281K sold.

Virtu Financial first reported a position in ADMA in Q4 2017 and held it in 9 quarters. The position peaked at $326K in Q4 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q4 2025.

  • Virtu Financial reported no remaining ADMA Biologics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 19,200 ADMA Biologics shares in Q4 2025, an estimated $281K.
  • Virtu Financial first reported a position in ADMA Biologics in Q4 2017 and held it in 9 quarters.
  • Virtu Financial's ADMA Biologics position peaked at $326K in Q4 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.